A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

BACKGROUND: There is significant interest in the use of stereotactic ablative radiotherapy (SABR) as a treatment modality for liver metastases. A variety of SABR fractionation schemes are in clinical use. We conducted a phase I dose-escalation study to determine the maximum tolerated dose of single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Jeffrey J., Foster, Ryan D., Lev-Cohain, Naama, Yokoo, Takeshi, Dong, Ying, Schwarz, Roderich E., Rule, William, Tian, Jing, Xie, Yang, Hannan, Raquibul, Nedzi, Lucien, Solberg, Timothy, Timmerman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Hepatobiliary Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695498/
https://www.ncbi.nlm.nih.gov/pubmed/25963478
http://dx.doi.org/10.1245/s10434-015-4579-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695498/
https://www.ncbi.nlm.nih.gov/pubmed/25963478
http://dx.doi.org/10.1245/s10434-015-4579-z

Ejemplares similares